Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Want to earn the most rewards on your purchases? Check out our top credit card picks that provide outstanding reward programs.
28,031 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Over the weekend, bitcoin mining difficulty drops by roughly 10%, highlighting ongoing stress on mining operations as...
SpaceX is stepping into a new AI infrastructure role, powering Anthropic’s Claude as a neo cloud. The move reshapes t...
SanDisk has surged to record highs, up 700% YTD, with AI-driven demand and supply constraints propelling the run. The...
Marques Colston and Nick Edwards unveil the Champion Fund, inviting fans to invest in sports with a $500 entry. The p...
Sotera Health has delivered a solid return over the last 12 months. Yet a sizable fund recently unloaded millions of ...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
Alphractal's latest index shows Bitcoin leads the four major PoW assets, but mining profits across bitcoin remain bel...
EOS Energy Enterprises sparked a notable move in today’s trading. This article breaks down the possible catalysts beh...
A fresh look at HAIN's Q3 2026 earnings and what it means for investors. Learn the metrics that matter, how to read t...
TIAA's leader recalls starting with a modest $26,000 salary and still maxing out her 401(k), underscoring the long-te...
Kroger reports fiscal 2025 results with a GAAP payout surge caused by a major impairment, yet cash flow and 2026 earn...